SI0719788T1 - Process for preparing 1-(2'-deoxy-2',2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one) hydrochloride - Google Patents

Process for preparing 1-(2'-deoxy-2',2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one) hydrochloride

Info

Publication number
SI0719788T1
SI0719788T1 SI9530272T SI9530272T SI0719788T1 SI 0719788 T1 SI0719788 T1 SI 0719788T1 SI 9530272 T SI9530272 T SI 9530272T SI 9530272 T SI9530272 T SI 9530272T SI 0719788 T1 SI0719788 T1 SI 0719788T1
Authority
SI
Slovenia
Prior art keywords
aminopyrimidin
ribofuranosyl
deoxy
difluoro
hydrochloride
Prior art date
Application number
SI9530272T
Other languages
English (en)
Slovenian (sl)
Inventor
Richard Alan Berglund
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23397211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0719788(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of SI0719788T1 publication Critical patent/SI0719788T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI9530272T 1994-12-13 1995-11-09 Process for preparing 1-(2'-deoxy-2',2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one) hydrochloride SI0719788T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/355,372 US5637688A (en) 1994-12-13 1994-12-13 Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
EP95308030A EP0719788B1 (fr) 1994-12-13 1995-11-09 Procédé pour la préparation de l'hydrochlorure de 1-(2'-deoxy-2',2'-difluoro-D-ribofuranosyl)-4-amino-pyrimidine-2-one

Publications (1)

Publication Number Publication Date
SI0719788T1 true SI0719788T1 (en) 1999-10-31

Family

ID=23397211

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530272T SI0719788T1 (en) 1994-12-13 1995-11-09 Process for preparing 1-(2'-deoxy-2',2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one) hydrochloride

Country Status (31)

Country Link
US (2) US5637688A (fr)
EP (1) EP0719788B1 (fr)
JP (1) JPH10510806A (fr)
KR (1) KR100424991B1 (fr)
CN (1) CN1047177C (fr)
AR (1) AR001041A1 (fr)
AT (1) ATE179986T1 (fr)
AU (1) AU689674B2 (fr)
BG (1) BG62738B1 (fr)
BR (1) BR9509979A (fr)
CO (1) CO4520286A1 (fr)
CZ (1) CZ290941B6 (fr)
DE (1) DE69509624T2 (fr)
DK (1) DK0719788T3 (fr)
ES (1) ES2130542T3 (fr)
GR (1) GR3030265T3 (fr)
HU (1) HU219021B (fr)
IL (1) IL115852A (fr)
MY (1) MY112488A (fr)
NO (1) NO306783B1 (fr)
NZ (1) NZ296476A (fr)
PE (1) PE49296A1 (fr)
PL (1) PL181732B1 (fr)
RO (1) RO117327B1 (fr)
RU (1) RU2154648C2 (fr)
SI (1) SI0719788T1 (fr)
TW (1) TW379226B (fr)
UA (1) UA48152C2 (fr)
WO (1) WO1996018637A1 (fr)
YU (1) YU49314B (fr)
ZA (1) ZA959320B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
EP0870506A1 (fr) * 1997-04-11 1998-10-14 Eli Lilly And Company Compositions comprenant un dérivé de la cryptophycine associé à un agent de synchronisation ou d'activation pour le traitement du cancer
DE69833509T2 (de) * 1997-12-22 2006-10-26 Schering Corp. Benzocycloheptapyridinezusammensetzungen und antineoplastische arzneimittel als kombinationstherapeutika für therapie der zellproliferation
US6376470B1 (en) 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
AU2001296558A1 (en) * 2000-10-03 2002-04-15 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
WO2005014010A1 (fr) * 2003-07-24 2005-02-17 Eli Lilly And Company Preparations pharmaceutiques comprenant de la gemcitabine et de la cyclodextrine
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
WO2006015346A1 (fr) * 2004-07-30 2006-02-09 Pharmaessentia Corp. SYNTHÈSE STÉRÉOSÉLECTIVE DE β-NUCLÉOSIDES
WO2006070985A1 (fr) * 2004-12-30 2006-07-06 Hanmi Pharm. Co., Ltd. Méthode de synthèse de la 2’-désoxy-2’,2’-difluorocytidine
AU2005328519B2 (en) * 2005-03-04 2012-03-01 Fresenius Kabi Oncology Limited Intermediate and process for preparing of beta- anomer enriched 21deoxy, 21 ,21-difluoro-D-ribofuranosyl nucleosides
WO2006095359A1 (fr) * 2005-03-10 2006-09-14 Sms Pharmaceuticals Limited Synthese du 2-desoxy-2,2-difluoro-d-ribofuranose-3,5-di(4-methyl-4-nitro-chloro)benzoate et sa conversion en chlorhydrate de gemcitabine
US7485716B2 (en) * 2005-05-02 2009-02-03 Pharmaessentia Corp. Stereoselective synthesis of β-nucleosides
CN100391966C (zh) * 2005-06-17 2008-06-04 华东师范大学 一种2’-脱氧-2’，2’-二氟-胞苷合成的方法
EP1940859A1 (fr) 2005-10-28 2008-07-09 Arch Pharmalabs Limited Procede ameliore de preparation de gemcitabine hydrochlorure
KR101259637B1 (ko) * 2005-12-14 2013-04-30 주식회사종근당 1-(2´-데옥시-2´,2´-디플루오로-디-리보푸라노실)-4-아미노피리미딘-2-온또는 그의 염산염의 제조방법
US20090069354A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched gemcitabine
JO2778B1 (en) 2007-10-16 2014-03-15 ايساي انك Certain vehicles, installations and methods
AU2008323923A1 (en) * 2007-11-06 2009-05-14 Pharmaessentia Corporation Novel synthesis of beta-nucleosides
IT1393062B1 (it) * 2008-10-23 2012-04-11 Prime Europ Therapeuticals Procedimento per la preparazione di gemcitabina cloridrato
WO2010118013A1 (fr) * 2009-04-06 2010-10-14 Eisai Inc. Association comprenant des médicaments antinéoplasiques à base de cytidine et un inhibiteur de la cytidine désaminase et utilisation de cette association dans le traitement du cancer
JO3262B1 (ar) * 2009-04-06 2018-09-16 Otsuka Pharma Co Ltd توليفة من ديسيتابين مع مثبط سيتيدين دي أميناز واستخدامها في علاج السرطان
US8609631B2 (en) 2009-04-06 2013-12-17 Eisai Inc. Compositions and methods for treating cancer
US8324180B2 (en) * 2009-04-06 2012-12-04 Eisai Inc. Compositions and methods for treating cancer
CN101525361B (zh) * 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
WO2010131475A1 (fr) * 2009-05-15 2010-11-18 大鵬薬品工業株式会社 NOUVEAU CRISTAL STABLE DE MONOCHLORHYDRATE DE 1-(2'-CYANO-2'-DESOXY-β-D-ARABINOFURANOSYL)CYTOSINE
CN101628927B (zh) * 2009-08-07 2012-10-10 卡硼瑞（北京）科技有限公司 以1,3,5-三-O-苯甲酰基-α-D-呋喃核糖为原料立体选择性制备β-二氟胞苷盐酸盐的方法
CN102453064B (zh) * 2011-06-30 2014-07-09 江苏豪森药业股份有限公司 制备吉西他滨盐酸盐的方法
CN102659884B (zh) * 2012-04-23 2014-07-02 南京臣功制药股份有限公司 盐酸吉西他滨的提纯方法
CN103224541B (zh) * 2013-04-27 2015-07-01 江苏豪森药业股份有限公司 吉西他滨α-异构体转化回收工艺
CN104402945A (zh) * 2014-11-27 2015-03-11 苏州乔纳森新材料科技有限公司 一种3-脱氧-1,2-o-异丙叉-d-呋喃木糖的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817978A (en) * 1971-06-16 1974-06-18 Syntex Inc 4-fluoro nucleosides and sugar intermediates, and methods of preparing
JPS5924999B2 (ja) * 1978-06-10 1984-06-13 富山化学工業株式会社 新規な５−フルオロ−２′−デオキシ−β−ウリジン誘導体の製造法
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
EP0184365B1 (fr) * 1984-12-04 1993-08-04 Eli Lilly And Company Traitement de tumeurs chez les mammifères
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US5223608A (en) * 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
AU4134793A (en) * 1992-06-22 1993-12-23 Eli Lilly And Company 2'-deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
KR940005654A (ko) * 1992-06-22 1994-03-22 리로이 휘테커 입체선택적인 음이온 글리코실화 방법
TW356472B (en) * 1992-09-01 1999-04-21 Lilly Co Eli A process for anomerizing nucleosides
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride

Also Published As

Publication number Publication date
BR9509979A (pt) 1998-06-09
CN1047177C (zh) 1999-12-08
MX9704322A (es) 1997-09-30
AR001041A1 (es) 1997-09-24
TW379226B (en) 2000-01-11
NO972679D0 (no) 1997-06-11
ES2130542T3 (es) 1999-07-01
GR3030265T3 (en) 1999-08-31
NZ296476A (en) 1998-12-23
WO1996018637A1 (fr) 1996-06-20
CN1169728A (zh) 1998-01-07
UA48152C2 (uk) 2002-08-15
CZ290941B6 (cs) 2002-11-13
NO306783B1 (no) 1999-12-20
JPH10510806A (ja) 1998-10-20
RO117327B1 (ro) 2002-01-30
HU219021B (hu) 2001-01-29
DE69509624D1 (de) 1999-06-17
AU689674B2 (en) 1998-04-02
ZA959320B (en) 1997-05-05
EP0719788A3 (fr) 1996-09-25
BG101591A (en) 1998-03-31
CO4520286A1 (es) 1997-10-15
IL115852A0 (en) 1996-01-31
DK0719788T3 (da) 1999-11-01
NO972679L (no) 1997-06-11
ATE179986T1 (de) 1999-05-15
BG62738B1 (bg) 2000-06-30
AU4110196A (en) 1996-07-03
US5808048A (en) 1998-09-15
PL181732B1 (en) 2001-09-28
PE49296A1 (es) 1996-11-21
EP0719788A2 (fr) 1996-07-03
RU2154648C2 (ru) 2000-08-20
YU70895A (sh) 1998-09-18
YU49314B (sh) 2005-06-10
CZ179897A3 (en) 1997-09-17
EP0719788B1 (fr) 1999-05-12
KR100424991B1 (ko) 2004-05-20
DE69509624T2 (de) 1999-10-07
IL115852A (en) 1999-09-22
HUT77929A (hu) 1998-11-30
MY112488A (en) 2001-06-30
PL321046A1 (en) 1997-11-24
US5637688A (en) 1997-06-10

Similar Documents

Publication Publication Date Title
ZA959320B (en) Process for preparing 1-(2'-deoxy-2',2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one) hydrochloride
NZ296712A (en) A process for purifying and isolating 2'-deoxy-2',2'-difluoronucleosides
HUP9802978A3 (en) Method for preparing 1,1,1,3,3-pentafluoropropane
EP0702008A3 (fr) Procédé pour la préparation de 1,2-benzisothiazol-3-ones
HUP0002105A3 (en) Method for preparing 1,1,1,3,3-pentachlorobutane
ZA958161B (en) Process for preparing 1,3-alkanediols and 3-hydroxyaldehydes
EP1023250A4 (fr) Procede de preparation de 2,6-dialkylnaphtalene
ZA958160B (en) Process for preparing 1,3-alkanediols and 3-hydroxyaldehydes
ZA966348B (en) Process for preparing 1,4,8,11 - tetraazacyclotetradecane.
HUP9902842A3 (en) Process for preparing 1-substituted 4-cyano-1,2,3-triazoles
IL117406A0 (en) Novel process for preparing 2,3-dihydro-benzofuranol derivatives
AU3113195A (en) Process for preparing 1,3-disubstituted imidazolidinones
IL113357A (en) Process for preparing alpha,alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid O, S-esters
IL116634A0 (en) Solventles process for making 2,6-difluorobenzonitrile
IL141048A0 (en) Process for preparing 3,5-difluoroaniline
AU3744495A (en) Process for preparing 1,3-alkanediols and 3-hydroxyldehydes
EP0751111A3 (fr) Procédé pour la préparation des 2,2-dialkylearylidène-cycloalcanones
EP0775705A3 (fr) Dérivé de la cyclopentenecarboxamide, méthode pour sa préparation et dérivé bicycloamidique utilisé dans cette méthode
AU1568895A (en) Process for preparing 2,6-dichloropyridine
ZA966897B (en) Process for preparing 1,4,8,11-tetraazacyclotetradecane.
HUP9701335A3 (en) Process for producing 1-(3,4-dimethoxy-phenol)-ethanol
ZA957615B (en) Process for R(+)1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenyl-3-cyclohexen-1-yl) methyl]pyridine a central nervous system agent
HUP9901426A3 (en) Method for preparing alpha, omega-bromochloroalkanes
GB9424890D0 (en) Process for preparing pyrolizine derivatives
GB2302871B (en) Process for preparing 1,1-dioxo-cephem-4-ketones